Botanical species · safety record

Packera aurea

The EFSA Compendium of Botanicals holds 3 constituent measurements and 1 adverse-effect record for Packera aurea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Packera aurea (L.) Á.Löve & D.Löve

3Constituent measurements
1Safety records
4Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids1
  • Otosenine1
  • Sesquiterpene alkaloids1

Plant parts

  • Live plants2
  • Aerial part of plants1
  • Unspecified1

Preparations

  • Solvent extraction4

Effect types

  • Hepatotoxicity1

Target tissues

  • Liver1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
OtosenineAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Sesquiterpene alkaloidsLive plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
AlkaloidsUnspecifiedSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverLive plantsSolvent extractionRat (as animal)Short-term toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Osuigwe, M.J., Margret, N. Evaluation of the toxicological effects of Senecio aureus extract on the liver and hematological parameters in wistar rats. Jordan journal of biological sciences, 2017, vol. 10, no. 1, p. 29-32.
  2. Kelly, Edgar A., Lynn, E. V. Chemical study of Senecio aureus. Journal of the american pharmaceutical association (1912-1977), 1931, vol. 20, p. 755-9.
  3. RESCH, JF., GOLDSTEIN, SA., MEINWALD, J. OTOSENINE FROM SENECIO-AUREUS. Planta medica, 1983, vol. 47, no. 4, p. 255-255. DOI
  4. NACHMAN, RJ. TETRAHYDROLIGULARENOLIDE AND RELATED EREMOPHILANES FROM SENECIO-AUREUS. Phytochemistry, 1983, vol. 22, no. 3, p. 780-782. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue